Parkinson Disease: all 4,583 studies
Page 41 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)Status unknownNCT01515774Phase 4
- Validation of the Hebrew Version of the Montreal Affective Voices.Status unknownNCT01512732
- Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With RotigotineCompletedNCT01504529
- Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's DiseaseCompletedNCT01504178Phase 3
- A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1/2
- Laser Light Visual Cueing for Freezing of Gait in Parkinson's DiseaseCompletedNCT01502995Phase 3
- A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) PatientsStatus unknownNCT01502384
- Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)WithdrawnNCT01500707Phase 1
- A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic TherapyCompletedNCT01497652Phase 4
- Imaging Biomarkers in Parkinson s DiseaseCompletedNCT01496599
- Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor StudyCompletedNCT01495897Not applicable
- Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491932Phase 2
- Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491529Phase 2
- Treatments for Insomnia in Patients With Parkinson's DiseaseCompletedNCT01489982Early Phase 1
- Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy VolunteersCompletedNCT01486628Phase 1
- Combined Deep Brain Stimulation for Parkinson's DiseaseWithdrawnNCT01485276Phase 1/2
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseCompletedNCT01484990Phase 1
- Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing- A Comparative Effectiveness StudyCompletedNCT01476306Not applicable
- Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot StudyCompletedNCT01469741Not applicable
- Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory CenterCompletedNCT01465360
- Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy SubjectsCompletedNCT01462708Phase 1
- Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy ControlsCompletedNCT01461109Phase 1
- Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1aCompletedNCT01461083Phase 1
- To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy VolunteersCompletedNCT01457807Phase 1
- Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's DiseaseWithdrawnNCT01453803Not applicable
- Imaging in the Diagnosis of Parkinson's Disease and Essential TremorStatus unknownNCT01446939
- Mesenchymal Stem Cells Transplantation to Patients With Parkinson's DiseaseStatus unknownNCT01446614Phase 1/2
- Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain StimulationCompletedNCT01446549Not applicable
- Effects of Rasagiline on Sleep Disturbances in Parkinson's DiseaseCompletedNCT01442610Phase 4
- A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainCompletedNCT01439100Phase 3
- Exercise Interventions in Parkinson's DiseaseCompletedNCT01439022Phase 2
- Ropinirole PR Pharmacokinetics Study Among Chinese Healthy SubjectsCompletedNCT01435915Phase 1
- Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's DiseaseCompletedNCT01429909Not applicable
- Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) ProgrammingCompletedNCT01429220
- Capturing Parkinson's Disease Medication Side Effects During Daily ActivitiesCompletedNCT01429207
- Impact of Dance Therapy on Parkinson's DiseaseWithdrawnNCT01428648Not applicable
- Local Field Potentials Recorded From Deep Brain Stimulating (DBS) ElectrodesCompletedNCT01427530
- Effects of an Innovative Balance Training Programme in Enhancing Postural Control and Reducing Falls in Patients With Parkinson's DiseaseStatus unknownNCT01427062Not applicable
- LRRK2 Mutation and Parkinson's DiseaseTerminatedNCT01424475Phase 1
- Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic Deep Brain Stimulation for Parkinson's DiseaseCompletedNCT01423565Not applicable
- Swallowing and Breathing Exercises for Dysphagia in Parkinson DiseaseCompletedNCT01420796Not applicable
- BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical ActivityStatus unknownNCT01417598Not applicable
- Treatment of Depression in Parkinson's DiseaseStatus unknownNCT01416818Phase 2
- Agricultural Health Study Follow-upCompletedNCT01399411
- Intranasal Glutathione in Parkinson's DiseaseCompletedNCT01398748Phase 1
- The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)CompletedNCT01391741Phase 3
- PD4PD:Partnered Dance for Parkinson DiseaseCompletedNCT01388556Phase 2/3
- Emotion, Mood and Executive Function in Parkinson's Disease (PD)Status unknownNCT01385735Phase 4
- Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01385592Phase 2
- The Effect of Rasagiline on Cognition in Parkinson's DiseaseCompletedNCT01382342Phase 4
- Trodat 1 SPECT and Dopamine PolymorphismCompletedNCT01381302
- Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism InvestigationStatus unknownNCT01378026
- Dual Task Practice in Parkinson's DiseaseCompletedNCT01375413Phase 3
- A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and ArandaCompletedNCT01371682Phase 1
- A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's DiseaseStatus unknownNCT01367782Not applicable
- PRISM Registry: Pseudobulbar Affect Registry SeriesCompletedNCT01366027
- Ketogenic Diets for Symptoms of Parkinson's DiseaseStatus unknownNCT01364545Not applicable
- COPE-Co-morbidities, Parkinson's Disease and ExerciseCompletedNCT01361724Not applicable
- Detecting Dopaminergic Deficits in Individuals At-risk for ParkinsonismCompletedNCT01358474
- Tele-diagnostics for Remote Parkinson's MonitoringCompletedNCT01356056
- Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's DiseaseCompletedNCT01355835Phase 2
- Analysis of the Enteric Nervous System Using Colonic BiopsiesCompletedNCT01353183Not applicable
- Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease StudyCompletedNCT01352819
- Web-based Genetic Research on Parkinson's DiseaseCompletedNCT01351467
- Use of Zolpidem in Parkinson's DiseaseWithdrawnNCT01351168Phase 2
- Bee Venom for the Treatment of Parkinson DiseaseCompletedNCT01341431Phase 2
- Assessment of Social-emotional Functioning in Neurological DiseasesCompletedNCT01339130Not applicable
- Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsCompletedNCT01338896Phase 1
- Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine AgonistStatus unknownNCT01338662
- Effectiveness Study of Occupational Therapy in Parkinson's DiseaseCompletedNCT01336127Not applicable
- ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's DiseaseCompletedNCT01336088Phase 2
- Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's DiseaseWithdrawnNCT01331122Phase 1/2
- Molecular Analysis of Human Neural Stem CellsWithdrawnNCT01329926
- Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With DementiaCompletedNCT01327859Phase 3
- Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's DiseaseCompletedNCT01323699Phase 1/2
- Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic HypotensionCompletedNCT01316666
- Facial Expression Recognition and Mirror Neurons in Parkinson's DiseaseStatus unknownNCT01315405Not applicable
- Effect of Intravenous Amantadine on Gait Freezing in Parkinson's DiseaseCompletedNCT01313845Phase 4
- The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic TherapyStatus unknownNCT01313819Phase 4
- Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's DiseaseCompletedNCT01306539Not applicable
- Robotic Locomotor Experience Applied to Parkinson's DiseaseStatus unknownNCT01302184Phase 2/3
- Effects of Virtual Reality Training in Patients With Parkinson's DiseaseCompletedNCT01301651Phase 1
- Long Term Follow-Up Study for rAAV-GAD Treated SubjectsTerminatedNCT01301573
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensCompletedNCT01296464Phase 2
- Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease PatientsCompletedNCT01291537Phase 2
- 18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PDCompletedNCT01286935Phase 3
- Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation.CompletedNCT01284699Not applicable
- Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's DiseaseCompletedNCT01284686Not applicable
- Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing OffCompletedNCT01283594Phase 2/3
- 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET ImagingCompletedNCT01283347Phase 2
- Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's DiseaseCompletedNCT01275573Phase 2
- Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD PatientStatus unknownNCT01274832
- Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype CorrelationCompletedNCT01272687
- Mapping and Manipulating the Emotional Territories of the Basal Ganglia in PD PatientsStatus unknownNCT01267409Not applicable
- A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain ImagingTerminatedNCT01264861Phase 2
- Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's PatientsTemporarily not availableNCT01262950
- Biofeedback to Ameliorate Freezing of GaitStatus unknownNCT01259635Not applicable
- Exercise for People With Parkinson's DiseaseCompletedNCT01257945Phase 2
- Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy BodiesWithdrawnNCT01256905Not applicable
- Dementia Registry for Parkinson's DiseaseCompletedNCT01251094